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Abstract
Background: Systematic reviews or randomised-controlled trials usually help to establish the
effectiveness of drugs and other health technologies, but are rarely sufficient by themselves to
ensure actual clinical use of the technology. The process from innovation to routine clinical use is
complex. Numerous computerised decision support systems (DSS) have been developed, but many
fail to be taken up into actual use. Some developers construct technologically advanced systems
with little relevance to the real world. Others did not determine whether a clinical need exists.
With NHS investing £5 billion in computer systems, also occurring in other countries, there is an
urgent need to shift from a technology-driven approach to one that identifies and employs the most
cost-effective method to manage knowledge, regardless of the technology. The generic term,
'decision tool' (DT), is therefore suggested to demonstrate that these aids, which seem different
technically, are conceptually the same from a clinical viewpoint.
Discussion: Many computerised DSSs failed for various reasons, for example, they were not based
on best available knowledge; there was insufficient emphasis on their need for high quality clinical
data; their development was technology-led; or evaluation methods were misapplied. We argue
that DSSs and other computer-based, paper-based and even mechanical decision aids are members
of a wider family of decision tools. A DT is an active knowledge resource that uses patient data to
generate case specific advice, which supports decision making about individual patients by health
professionals, the patients themselves or others concerned about them. The identification of DTs
as a consistent and important category of health technology should encourage the sharing of
lessons between DT developers and users and reduce the frequency of decision tool projects
focusing only on technology. The focus of evaluation should become more clinical, with the impact
of computer-based DTs being evaluated against other computer, paper- or mechanical tools, to
identify the most cost effective tool for each clinical problem.
Summary: We suggested the generic term 'decision tool' to demonstrate that decision-making
aids, such as computerised DSSs, paper algorithms, and reminders are conceptually the same, so
the methods to evaluate them should be the same.
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Backgound
Decision support systems as a potential tool to enhance 
the uptake of evidence
Many problems facing health care systems today are not
caused by lack of knowledge but by the gap between what
we know and what we do in the face of staff shortages,
economic pressures and rising public demand [1]. Sys-
tematic reviews or randomised-controlled trials of new
health technologies published in prestigious journals are
a linchpin of evidence based medicine and help to estab-
lish the effectiveness of drugs or procedures, but are rarely
enough to ensure that the technology is actually used.
The process from innovation to routine clinical use is
complex. For example, in cardiovascular disease preven-
tion, despite the systematic reviews, evidence-based
guidelines and decision tools (e.g. the Joint British
Charts), there is continuing evidence to suggest that these
approaches have not yet changed actual  clinical prac-
tice[2,3]. The Leeds Acute Abdominal Pain system [4],
which estimates patient-specific diagnostic probabilities
and underwent extensive development and testing over
decades, is scarcely used today. Many factors appear to
influence the uptake of these systems, and the guidelines
on which they are based[5]. For example, some health
professionals are unaware of, or simply forget, guideline
recommendations, while others fail to follow them
because of patient choice or peer pressure.
Hundreds of computerised decision support systems
(DSS) and other aids have been developed to assist
patient management. In Garg et al's systematic review of
controlled trials of DSSs, about two thirds of these are
effective at narrowing knowledge gaps, improving deci-
sions, clinical practice or patient outcomes [6], but many
are not (e.g. computer-based guidelines on the manage-
ment of angina and asthma[7]) Why did one third of the
computerised DSSs that were sufficiently mature to be
exposed to a randomised trial fail to influence clinical
actions in Garg et al's systematic review [6]? Reasons why
this might have happened include:
1. Failure of clinicians to use the DSS e.g. because they did
not understand what it was for, the prevailing clinical cul-
ture was against it, their patients or peer group objected to
it, it was too slow, or was not linked to the electronic
patient record (EPR).
2. The DSS did not produce an effective output in time to
influence their decision: e.g. the output was not available
in time; they could not understand the output.
3. The output was not convincing enough to persuade the
users to change their practice: e.g. the output showed poor
accuracy, was badly worded, users had never before heard
of this drug and required more details.
4. The output was available and was convincing enough to
influence user decisions, but the user was unable to
change their practice: e.g. the drug was too expensive to
prescribe, there was adverse peer or patient pressure, the
user was missing some vital information, equipment or
skill that they needed before being able to enact their deci-
sion.
5. The performance of the clinicians was already optimal,
given the circumstances and patient case mix.
Each of these potential reasons for failure needs to be con-
sidered carefully by DSS developers before they start work.
This means that DSS developers need to start with the
steps necessary to bring about the intended user actions or
behaviour, not with the improvement of the quality of
user decisions or the accuracy of the DSS itself. Those
wishing to improve clinical practice and patient outcomes
need to analyse the steps necessary to bring about the
intended change and accept that, quite often, a DSS will
not be the solution, as the long list of issues above dem-
onstrates. We are thus advocating that the development of
decision support systems need to shift from being tech-
nology led to problem led, and that a new mindset is
needed to encourage this.
Discussion
Problems with current decision support systems
Some developers seem to construct technologically
advanced systems with little relevance to the real world,
while others create DSSs without first determining
whether a clinical need exists[8,9]. We believe that there
should be a move away from this technology-driven
approach to one that entails identifying and employing
the most effective method to improve practice, regardless
of whether education, a high-tech personal digital assist-
ant or a low-tech paper reminder is used.
Computerised DSSs (also called 'decision aids' [10]) are
fundamentally no different from paper algorithms, nom-
ograms, reminders or other aids to clinical decision-mak-
ing, because they all aim to improve the appropriateness
of clinical decisions, actions and patient health outcomes.
Despite the concerns expressed above, we believe that this
is an important class of health technology for which a
consistent nomenclature is needed. We therefore suggest a
generic term, 'decision tool', to demonstrate that these
decision-making aids, which may seem very different
from a technical perspective, are conceptually the same
from a health technology assessment viewpoint. Exam-
ples of decision tools that do improve clinical practice
include reminders for doctors,[11,12] patient informa-BMC Medical Informatics and Decision Making 2006, 6:4 http://www.biomedcentral.com/1472-6947/6/4
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tion/support leaflets (e.g. O'Connor et al. [13]) and pre-
dictive scores (e.g. the paediatric logistic organ
dysfunction (PELOD) score[14], the Ottawa ankle
rules[15] and the Glasgow coma scale [16]). Computer-
based reminder systems have been shown to be effective
in increasing the use of preventive care in both inpatient
and outpatient settings [6,12]. Some empirical evidence
suggests that DSSs can have more impact than paper-
based guidelines and checklists[17].
This article discusses problems with contemporary deci-
sion support systems and the need to adopt a decision
tool 'mindset'. A formal definition of the term 'decision
tool' and of their characteristics is given below.
Although good evidence exists for the clinical benefit of
some DSSs, there are also numerous examples of failures
and difficulties, for various reasons:
First, until recently, DSSs were rarely based on the best
available knowledge. They should incorporate rigorous
evidence, e.g. knowledge derived from well-designed, rel-
evant studies or a large patient database.
Second, there has been insufficient emphasis on the need
for the health professional or patient to capture high qual-
ity clinical data for the DSS.
Third, the development of DSSs has too often been tech-
nology-led. Their true role, of improving decisions and
actions about individual patients, has frequently been
ignored. A closely related issue is that the most appropri-
ate method should be selected to overcome demonstrated
barriers to change[5], avoiding what Gremy has termed
the "idolatry of technology" by those working in medical
informatics[18]. Some barriers require education or
organisational change to abolish them, not a DSS at
al[17].
Fourth, health technology assessment methods (such as
studies on accuracy or impact, systematic reviews and eco-
nomic analyses) have frequently been misapplied [18,19].
Correct application of these methods is necessary to eval-
uate their impact on clinical practice and their cost-effec-
tiveness[20]. The cost-effectiveness of computer DSSs
compared with paper-based decision tools has seldom
been studied, and was missing from a recent large study
on computerized reminders in US hospitals [12].
A fifth problem has been failure to address broader legal
and ethical issues [21]. For example, health professionals
using DSSs should always apply their own clinical judge-
ment in the context of the patient and the encounter, and
not unthinkingly follow its advice. The system should be
designed to treat its user as a "learned intermediary" and
not act as a black box[21,22].
A sixth problem is that developers and users of DSSs have
too often failed to appreciate that effectiveness and cost-
effectiveness will vary according to the user and their con-
text.
Finally, DSS developers will need to become more aware
of regulatory issues. Although DSSs are currently exempt
from regulation, unlike the closed loop systems that
measure patient variables and automatically adjust a drug
infusion device for example, this may change[23]. For
example, the National Institute for Health and Clinical
Excellence in England is currently piloting methods to test
the clinical and cost effectiveness of DSS[24]. If this pilot
becomes a permanent NICE work programme, it will act
as a regulatory hurdle to the introduction of DSS into the
UK National Health Service.
Some of the above failures follow from insufficient clini-
cal and patient involvement, due partly to our failure to
recognise the role of different kinds of DSSs and their
underlying similarities. However, this position is likely to
change as more DSSs are used and some cause, rather than
prevent, medical errors.
Definition and characteristics of a decision tool
We propose the following definition of a decision tool: A
'decision tool' is an active knowledge resource that uses patient
data to generate case-specific advice which support decision
making about individual patients by health professionals, the
patients themselves or others concerned about them.
This definition is an updated and more general version of
Wyatt and Spiegelhalter's 1991 definition of computer
decision aids ("active knowledge systems which use two
The role of a decision tool in shared decisions Figure 1
The role of a decision tool in shared decisions. One possible 
typology of decision tools.
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Table 1: Assessment of a variety of aids to clinical decisions by decision tool criteria
Characteristics of decision tools
Tool User Designed to aid 
clinical decisions by 
health professional or 
patient?
Target decision 
Decisions about a 
real individual 
patient?
Knowledge component 
Does tool use 
knowledge to assist 
interpretation or aid 
clinical decision making
Timing Is tool used 
before health 
professional or patient 
makes the relevant 
decision?
1. Computerized reminder system for 
preventive care (e.g. Dexter et al [12])
Yes Yes Yes Yes
2. Paper reminder to check for sign X, 
take into account symptom Y or take 
action Z when seeing a patient (e.g. 
Bryce et al [26] and Eccles et al [11])
Yes Yes Yes Yes
3. Care pathway (e.g. Holtzman et al [27]) Yes Yes Yes Yes
4. Tool to enhance shared decision 
making [28]
Yes Yes Yes Yes
5. Computerised patient interviewing 
(checklist for patient to complete, after 
which the data are presented to the doctor 
in summary form (e.g. Lilford et al [29])
Yes Yes Yes Yes
6. Sheet for doctor giving definitions of 
clinical findings in acute abdominal 
pain or advice on how to elicit them
Yes Yes Yes Yes
7. Nomograms Yes Yes Yes Yes
8. Joint British Societies coronary risk 
prediction charts [2]
Yes Yes Yes Yes
9. Telemedicine system [30] Yes Yes Yes Yes
10. Information leaflet for patient with 
acute abdominal pain
Yes Yes Yes Yes
11. Sheet summarising results of special 
investigations with advice on interpreting 
results
Yes Yes Yes Yes
12. Distance learning material used 
away from patients (e.g. in a course, or 
self-study) (see examples in Davis et al 
[31])
Yes No Yes No
13. Monthly performance feedback report 
(i.e. giving doctors feedback about their 
performance on previous groups of patients)
Yes No No Yes
14. Computer simulator to help 
doctors develop their diagnostic skills 
(e.g. Hoffer & Barnett [32])
Yes No Yes Yes
15. Imaging investigation, e.g. 
ultrasonography, computed tomography
Yes Yes No Yes
16. Laboratory test, e.g. white cell 
count, C-reactive protein
Yes Yes No Yes
17. Audit on clinical activities in a GP surgery No No No No
or more items of patient data to generate case-specific
advice")[20]. Figure 1 illustrates the generic role of a deci-
sion tool in the clinical consultation process and the flow
of information between the patient, doctor and decision
tool. The arrows in the figure represent pathways that
information can take to and from the tool, doctor, patient,
and diagnostic equipment.
In our model, decision tools have four important charac-
teristics that can be readily transformed into criteria
(Table 1):
i) The target decision maker: the tool is designed to aid a clinical 
decision by a health professional and/or patient
This characteristic highlights the importance of shared
decision-making between health professionals and
patients. Decision aids for health professionals and
patients are both included. If the patient is unable to make
an informed decision (e.g. a child or someone in a coma),
then a carer or relative familiar with his or her condition
is an appropriate proxy.BMC Medical Informatics and Decision Making 2006, 6:4 http://www.biomedcentral.com/1472-6947/6/4
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ii) The target decision: the decisions concern an individual patient
The focus is on decisions about an identified individual
patient, rather than on groups of patients (e.g. to support
health policy) or on hypothetical patients (e.g. for teach-
ing purposes).
iii) The knowledge component: the tool uses patient data and 
knowledge to generate an interpretation that aids clinical decision-
making
A decision tool must contain some embedded knowledge
to help a health professional or patient use patient data to
generate an interpretation or aid to decision-making.
Examples include: explicit advice, such as a printed rec-
ommendation for a course of action; interpretation, such
as an asterisk meaning "this result is abnormal" or a pre-
dicted probability of death for an ICU patient; and
reminders or alerts, such as "This patient is allergic to pen-
icillin."
iv) Timing: the tool is used before the health professional or patient 
takes the relevant decision
A tool used retrospectively, after the relevant decision has
been finally taken, is excluded. However, tools that inter-
pret patient data such as a test result after a clinical
encounter can still be classified as decision tools if their
output is used to inform a later decision, for example to
help the patient manage their own disease at home or dur-
ing the next clinical encounter.
Possible objections to the label "Decision tool"
Our proposed term, decision tool, includes the classical
computer based decision support systems. Those develop-
ing DSSs might reject our blanket category, claiming sig-
nificant differences between subclasses of these systems
(e.g. how a specific tool works or is developed), in the
same way that a chemist will recognise molecular differ-
ences between the individual drugs that form a single
therapeutic class. However, from certain clinical and
health policy perspectives, such differences are often irrel-
evant, as is often the case with drugs from the same thera-
peutic class.
We also disagree with some technologists[25] and believe
there is essentially no difference between the methods
used to evaluate a new drug or a new decision tool. While
qualitative methods are necessary to help elucidate barri-
ers to change, requirements for a decision tool or reasons
for failure, there is no alternative to rigorous study designs
such as the randomised controlled trial to reliably quan-
tify a tool's impact on clinical decisions, actions or patient
outcomes. Systematic reviews demonstrate the feasibility
of conducting RCTs, for example Garg et al found one
hundred RCTs of computer based DSS [6].
Examples of decision tools
Table 1 provides examples of tools with and without the
above characteristics. A care pathway (Example 3) is a pre-
printed record designed to aid health professionals in
recording data and interpreting them as well as in making
decisions (fulfilling characteristics 1 and 4) about an indi-
vidual patient (characteristic 2). It is a knowledge resource
for health professionals that enables them to actively use
patient data to make decisions (characteristic 3). Clearly,
care pathways are decision tools.
Some examples of aids that are not decision tools include
distance learning material used away from patients
(Example 12) and imaging investigations/laboratory tests
(Examples 15 and 16), which are not knowledge resources
(characteristic 3). However, an algorithm or other tool to
support interpretation of the results of such tests is a deci-
sion tool. For example, a sheet summarising test results
would be included if it included knowledge on how to
interpret the results and obtain predictions that inform
patient management. Some examples depend on the user
and current task. For example, a computer-based simula-
tor used to help physicians develop their diagnostic skills
would not be a decision tool if the data they enter are not
about a patient they are managing (Example 14). How-
ever, it is a decision tool if they enter data about a real
One possible typology of decision tools Figure 2
One possible typology of decision tools.
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patient. An audit of a GP surgery's clinical activities fails to
have any of the characteristics and is not a decision tool
(Example 17). The typology in Figure 2 shows one way to
visualise the diversity of decision tools.
Recommendations
We have argued that DSSs and other computer-based,
paper-based and even mechanical clinical decision aids
are members of a wider family that we call decision tools.
By viewing decision tools as a group their role in health
care becomes clearer, which should encourage clinical
involvement in developing such tools and evaluating their
impact on clinical practice. The excessive emphasis on
technology to date has probably resulted from lack of bal-
ance in the involvement of clinicians and informatics
experts or computer scientists, some of whom did not
appreciate the crucial need for input from clinicians and
epidemiologists in the development and testing of these
tools. Equally, it is likely that most clinicians do not
appreciate the potential of these tools as a crucial step in
helping implement the evidence form rigorous studies.
The identification of decision tools as a coherent and
important category of health technology should encour-
age the involvement of clinicians and sharing of lessons
between decision tool developers and users, reduce the
frequency of decision tool projects focusing only on tech-
nologies, and reduce silo thinking by those in both clini-
cal and informatics disciplines.
We believe that the focus of evaluation should thus
become more clinical. For tools that are designed to help
improve clinical practice – as opposed to exploring some
technical issue – it is not sufficient to evaluate the accuracy
of the tool compared with routine clinical practice or a
gold standard[20]. Rather, its impact should be evaluated
against other computer, paper- or even mechanical tools,
in order to identify the most cost-effective tool for each
clinical problem. It is unlikely that the most cost-effective
option will always be computer-based.
How should adoption of this decision tool mindset be
encouraged? Authors and editors could be encouraged to
use the term in titles and abstracts. We propose the inclu-
sion of 'decision tool' as a new Medical Subject Heading
(MeSH) term to aid the identification of empirical studies
for clinical and research purposes. A joint clinician and
decision tool developers' network could be established,
with an infrastructure including e-mail lists, web support
materials, conferences and a co-ordinating resource cen-
tre. Finally, a case can be made for multidisciplinary R&D
programmes on decision tools, jointly supported by clin-
ical and informatics funding bodies. Table 2 illustrates
our viewpoint by contrasting the "old think" of many DSS
projects with the approach that makes sense for those who
wish to consider using decision tools as a promising tech-
nology to help get evidence into practice.
Summary
Some developers of DSSs have constructed technologi-
cally advanced systems with little relevance to the real
world, while others created DSSs without first determin-
ing whether a clinical need exists. Computerised DSSs are
fundamentally no different from paper algorithms, nom-
ograms, reminders or other aids to clinical decision-mak-
ing, because they all aim to improve the appropriateness
of clinical actions and patient health outcomes. We there-
fore suggest the generic term, 'decision tool', to demon-
strate that these decision-making aids, which may seem
very different from a technical perspective, are conceptu-
ally the same from a clinical viewpoint. A decision tool is
an active knowledge resource that uses patient data to gen-
erate case specific advice, which support decision making
about individual patients by health professionals, the
patients themselves or others concerned about them. The
Table 2: The contrast between the "old think" of many DSS projects and the "new think" that considers decision tools as a potential 
technology to help get evidence into practice.
Old think New think
Complex computerised decision support system that demands respect 
and understanding
A discrete decision tool with the complexity concealed within a simple 
functional exterior
Hard technical problems are the main focus Hard knowledge management problems are the main focus
Evaluation should focus on the DSS Evaluation should focus on the knowledge problems
The technology dominates the project The problem dominates the project
Select problems that DSS can address Focus on a knowledge problem and match the solution to this – ignoring 
DSS if need be
Improved decisions are the end point Getting evidence into practice is the end point
The important distinctions are between DSS reasoning methods The important distinctions are between different knowledge 
management problems and their causesBMC Medical Informatics and Decision Making 2006, 6:4 http://www.biomedcentral.com/1472-6947/6/4
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impact of computer-based decision tools should be eval-
uated against other computer, paper- or even mechanical
tools, in order to identify the most cost effective option,
which is unlikely to be always computer-based.
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DSS: Decision support system
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